Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.
History
Dendrite Clinical Systems was established in 1993, by co-directors Dr Peter Walton, Keith Price and Neal McCann, and over the last 26 years the company has become one of the leading suppliers of clinical software to hospitals and institutions in the world. Since its inception, the company has maintained a belief that clinical data collection and analysis is crucial in achieving effective clinical audit and ultimately, improving patient outcomes.
Starting from an office in central London, Dendrite has evolved from a specialist supplier of clinical databases and analysis software, to providing consultancy and publishing services for the international healthcare sector. The company now has two offices in the UK, agents across four continents and has expanded its global user base across hundreds of hospitals, with over 170 national and international registries in more than 40 countries.
Dendrite has continued to develop innovative clinical software solutions, which have been utilised in many different clinical scenarios, fulfilling the company's ethos of providing the tools for effective clinical governance.
